Published Jun 27, 2022

The Science & Treatment of Obsessive Compulsive Disorder (OCD) | Huberman Lab Podcast #78

Andrew Huberman delves into the complexities of OCD, examining its neural mechanisms and differentiating it from OCPD, while exploring both behavioral and pharmacological treatments. The episode presents a comprehensive analysis of therapies like CBT and exposure therapy, alongside discussions on SSRIs and emerging treatments such as ketamine and cannabis.
Episode Highlights
Huberman Lab logo

Popular Clips

Questions from this episode

Episode Highlights

  • SSRIs & CBT

    Selective serotonin reuptake inhibitors (SSRIs) are commonly prescribed for OCD, but they are not always effective for everyone. explains that while SSRIs can reduce OCD symptoms, many patients do not respond to them or cognitive behavioral therapy (CBT) alone. He emphasizes the importance of combining treatments, noting that adding CBT to an existing SSRI regimen can further alleviate symptoms 1.

    Drug treatments seem less powerful though. If you're already on a drug treatment, adding cognitive behavioral therapy can really help.

    ---

    Huberman also highlights the role of neuromodulators like dopamine and serotonin in influencing brain circuits, which can impact the effectiveness of these treatments 2.

       

    Experimental Options

    Experimental treatments for OCD, such as ketamine and cannabis, are gaining attention in the research community. discusses ketamine's potential, noting its action on the glutamate system and its use in treating trauma and depression. However, he cautions that more extensive clinical trials are needed to confirm its efficacy for OCD 3.

    Ketamine therapy, the jury is still out, psilocybin, The jury is still out. These are early days.

    ---

    Cannabis, another explored option, shows limited acute impact on OCD symptoms, despite some anecdotal reports of anxiety reduction 4.

Related Episodes